Revvity (RVTY) Competitors $90.91 +1.46 (+1.63%) Closing price 08/15/2025 03:58 PM EasternExtended Trading$90.78 -0.13 (-0.15%) As of 08/15/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVTY vs. BRKR, TECH, A, DHR, IQV, MTD, TMO, WAT, KEYS, and VLTOShould you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), Keysight Technologies (KEYS), and Veralto (VLTO). Revvity vs. Its Competitors Bruker Bio-Techne Agilent Technologies Danaher IQVIA Mettler-Toledo International Thermo Fisher Scientific Waters Keysight Technologies Veralto Revvity (NYSE:RVTY) and Bruker (NASDAQ:BRKR) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment. Does the media refer more to RVTY or BRKR? In the previous week, Bruker had 8 more articles in the media than Revvity. MarketBeat recorded 21 mentions for Bruker and 13 mentions for Revvity. Revvity's average media sentiment score of 1.36 beat Bruker's score of 0.36 indicating that Revvity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revvity 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 4 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Which has stronger valuation & earnings, RVTY or BRKR? Revvity has higher earnings, but lower revenue than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevvity$2.76B3.83$270.39M$2.3638.52Bruker$3.44B1.48$113.10M$0.5264.46 Do analysts rate RVTY or BRKR? Revvity presently has a consensus price target of $120.07, indicating a potential upside of 32.08%. Bruker has a consensus price target of $51.30, indicating a potential upside of 53.04%. Given Bruker's higher possible upside, analysts plainly believe Bruker is more favorable than Revvity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revvity 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.71Bruker 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 Is RVTY or BRKR a better dividend stock? Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.6%. Revvity pays out 11.9% of its earnings in the form of a dividend. Bruker pays out 38.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has more volatility and risk, RVTY or BRKR? Revvity has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Bruker has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Is RVTY or BRKR more profitable? Revvity has a net margin of 10.19% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 17.89% beat Revvity's return on equity.Company Net Margins Return on Equity Return on Assets Revvity10.19% 7.66% 4.73% Bruker 2.31%17.89%5.38% Do insiders and institutionals have more ownership in RVTY or BRKR? 86.7% of Revvity shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.7% of Revvity shares are owned by company insiders. Comparatively, 27.3% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryRevvity and Bruker tied by winning 9 of the 18 factors compared between the two stocks. Get Revvity News Delivered to You Automatically Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVTY vs. The Competition Export to ExcelMetricRevvityMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$10.38B$7.55B$5.67B$20.96BDividend Yield0.31%2.79%3.79%3.58%P/E Ratio38.5273.3830.5827.94Price / Sales3.8331.08464.2456.18Price / Cash10.5125.7937.4023.77Price / Book1.4017.309.095.26Net Income$270.39M$243.10M$3.25B$994.11M7 Day Performance4.56%3.01%7.42%1.79%1 Month Performance-4.23%1.52%5.50%1.73%1 Year Performance-24.03%18.72%30.67%13.35% Revvity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVTYRevvity3.4312 of 5 stars$90.91+1.6%$120.07+32.1%-24.3%$10.38B$2.76B38.5211,000Positive NewsBRKRBruker4.962 of 5 stars$34.72-8.6%$53.10+52.9%-47.0%$5.76B$3.37B66.7711,396Dividend AnnouncementHigh Trading VolumeTECHBio-Techne4.9585 of 5 stars$54.880.0%$69.58+26.8%-28.4%$8.60B$1.16B66.933,100Positive NewsDividend AnnouncementAAgilent Technologies4.8776 of 5 stars$114.99+1.3%$139.77+21.5%-14.7%$32.24B$6.51B28.3917,900Positive NewsDHRDanaher4.7447 of 5 stars$197.50+0.2%$247.61+25.4%-21.7%$141.13B$23.88B42.0263,000Positive NewsAnalyst RevisionIQVIQVIA4.9135 of 5 stars$182.97+0.3%$228.62+24.9%-20.6%$31.02B$15.41B26.4888,000Positive NewsShort Interest ↓Analyst RevisionMTDMettler-Toledo International3.979 of 5 stars$1,230.69+2.8%$1,300.00+5.6%-8.3%$24.88B$3.87B31.1617,300Positive NewsInsider TradeTMOThermo Fisher Scientific4.9529 of 5 stars$467.41+0.9%$593.00+26.9%-18.8%$174.79B$42.88B27.03125,000Positive NewsAnalyst RevisionWATWaters4.7946 of 5 stars$285.97-1.5%$380.40+33.0%-14.4%$17.28B$2.96B25.957,600KEYSKeysight Technologies4.2766 of 5 stars$161.65+1.9%$187.50+16.0%+23.1%$27.31B$4.98B37.9515,500Positive NewsUpcoming EarningsVLTOVeralto2.569 of 5 stars$106.93+2.1%$114.00+6.6%-1.7%$25.99B$5.19B28.1617,000Positive News Related Companies and Tools Related Companies Bruker Alternatives Bio-Techne Alternatives Agilent Technologies Alternatives Danaher Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Thermo Fisher Scientific Alternatives Waters Alternatives Keysight Technologies Alternatives Veralto Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RVTY) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revvity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revvity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.